Soluble Fas and soluble Fas-ligand in children with Escherichia coli O157:H7-Associated hemolytic uremic syndrome

American Journal of Kidney Diseases

Volumn 36, Issue 4, 2000, Pages 687-694

  Masri, Christian ^a,b,c   Proulx, François ^a,b,c   Toledano, Baruch ^a,b,c   Clermont, Marie José ^a,b,c   Mariscalco, Michelle M ^a,b,c   Seidman, Ernest G ^a,b,c   Carcillo, Joseph ^a,b,c  

^a UNIVERSITY OF MONTREAL   (Canada)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

Antigen CD95; Apoptosis; Child; Escherichia coli(E coli); Hemolytic uremic syndrome (HUS)

Indexed keywords

FAS ANTIGEN; FAS LIGAND;

ADOLESCENT; APOPTOSIS; ARTICLE; CHILD; CONTROLLED STUDY; DISEASE SEVERITY; ESCHERICHIA COLI O157; FEMALE; GLOMERULUS FILTRATION RATE; GRAM NEGATIVE INFECTION; HEMOLYTIC UREMIC SYNDROME; HUMAN; IMMUNOPATHOGENESIS; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRESCHOOL CHILD; SCHOOL CHILD;

EID: 0033815718     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/ajkd.2000.17612     Document Type: Article

References (43)

1. Hamolytisch-uramische syndrome: Bilaterale nierenrindennekrosen bei akuten erworbenen hamolytischen anamien
2. The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli
3. Epidemiology of hemolytic uremic syndrome in Canadian children from 1986 to 1988
4. Tumor necrosis factor and interleukin-1 induce expression of the verocytotoxin receptor globotriaosylceramide on human endothelial cells: Implications for the pathogenesis of the hemolytic uremic syndrome
5. Shiga toxin-associated hemolytic uremic syndrome: Combined cytotoxic effects of Shiga toxin, interleukin-1 β, and tumor necrosis factor a on human vascular endothelial cells in vitro
6. Shiga-toxin- 1 regulation of cytokine production by human proximal tubule cells
7. Monocyte chemoattractant protein-1 and interleukin- 8 in urine and serum of patients with hemolytic uremic syndrome
8. Inflammatory mediators in hemorrhagic colitis and hemolytic uremic syndrome
9. Circulating inflammatory cytokine levels predict severity of renal failure in hemolytic uremic syndrome
10. Circulating levels of transforming growth factor beta 1 and lymphokines in children with hemolytic uremic syndrome
11. Increased circulating levels of lipopolysaccharide binding protein in children with Escherichia coli O157:H7 hemorrhagic colitis and hemolytic uremic syndrome
12. Plasma cytokine levels in hemolytic uremic syndrome
13. Cytokines in childhood hemolytic uremic syndrome and thrombotic thrombocytopenic purpura
14. Interleukin- 8 and polymorphoneutrophil leukocyte activation in hemolytic uremic syndrome of childhood
15. Renal histopathology in fatal cases of diarrhea-associated haemolytic uraemic syndrome
16. Virulence of enterohemorrhagic Escherichia coli: Role of molecular cross-talk
17. The histopathology of the hemolytic uremic syndrome associated with verocytotoxin-producing Escherichia coli infections
18. Plasma soluble Fas and soluble Fas ligand in chronic glomerulonephritis
19. Plasma sFas and sFas ligand levels in patients with thrombotic thrombocytopenic purpura and in those with disseminated intravascular coagulation
20. Apoptosis of microvascular endothelial cells in the pathophysiology of thrombotic thrombocytopenic purpura/sporadic hemolytic uremic syndrome
21. Apoptosis induced in Burkitt's lymphoma cells via Gb3/CD 77, a glycolipid antigen
22. Verocytotoxin- 1 induces apoptosis in vero cells
23. Apoptosis of renal cortical cells in the hemolytic uremic syndrome: In vivo and in vitro studies
24. Verotoxins induce apoptosis in human renal tubular epithelium derived cells
25. An easy procedure for glomerular filtration rate determination in children using Tc-99m DTPA, one plasma sample and external counting with a thyroid probe
26. Purification and characterization of the Fas-ligand that induces apoptosis
27. Fas and Fas ligand expression on human peripheral blood leukocytes
28. Differential expression of Fas (CD95) and Fas ligand on normal human phagocytes: Implications for the regulation of apoptosis in neutrophils
29. Regulation of apoptosis in neutrophils - Fas track to death?
30. Metalloproteinase-mediated release of human Fas-ligand
31. Fas ligand in human serum
32. Thrombotic thrombocytopenic purpura and sporadic hemolytic-uremic syndrome plasmas induce apoptosis in restricted lineages of human microvascular endothelial cells
33. Potential for involvement of Fas antigen/Fas ligand interaction in apoptosis of epithelial cells by intraepithelial lymphocytes in murine small intestine
34. Susceptibility to Fas-induced apoptosis in humoral non-tumoral enterocytes: The role of co-stimulatory factors
35. Neutrophil elastases and haemolytic uraemic syndrome
36. Leukocytosis in hemolytic-uremic syndrome
37. Protection from Fasmediated apoptosis by a soluble form of the Fas molecule
38. Identification of soluble APO-1 in supernatants of human B- and T-cell lines and increased serum levels in B- and T-cell leukemia
39. Inhibition of neutrophil apoptosis by verotoxin 2 from Escherichia coli O157:H 7
40. Lipopolysaccharide, tumor necrosis factor-α and IL-1β prevent programmed cell death (apoptosis) in human peripheral blood monocytes
41. Protection from Fasmediated apoptosis by a soluble form of the Fas molecule
42. Circulating soluble Fas receptor and soluble Fas ligand and the development of pediatric sepsis-induced multiple organ failure